Wai Yuen Tong Medicine Holdings Limited (HKG:0897)
Hong Kong
· Delayed Price · Currency is HKD 0.3600
+0.0100 (2.86%)
Apr 24, 2025, 3:28 PM HKT
HKG:0897 Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Revenue | 762.4 | 783.88 | 723.6 | 1,391 | 1,109 | 620.74 | Upgrade
|
| Revenue Growth (YoY) | 26.08% | 8.33% | -47.99% | 25.52% | 78.59% | -17.39% | Upgrade
|
| Cost of Revenue | 372.98 | 389.07 | 381.24 | 817.26 | 666.63 | 338.5 | Upgrade
|
| Gross Profit | 389.42 | 394.81 | 342.36 | 574.15 | 441.93 | 282.24 | Upgrade
|
| Selling, General & Admin | 383.24 | 354.98 | 331.52 | 499.2 | 429.26 | 405.43 | Upgrade
|
| Operating Expenses | 383.18 | 353.93 | 337.37 | 504.58 | 428.1 | 414.6 | Upgrade
|
| Operating Income | 6.24 | 40.88 | 4.99 | 69.58 | 13.83 | -132.36 | Upgrade
|
| Interest Expense | -35.58 | -40.79 | -29.51 | -95.7 | -107.72 | -52.78 | Upgrade
|
| Interest & Investment Income | 47.2 | 48.24 | 47.13 | 25.35 | 29.66 | 82.28 | Upgrade
|
| Earnings From Equity Investments | 1.79 | 2.53 | 2.95 | 1.57 | 4.65 | 15.18 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.51 | -2.63 | -3.71 | 6.97 | 2.07 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 4.64 | 7.91 | 5.06 | 55.29 | 72.57 | 21.05 | Upgrade
|
| EBT Excluding Unusual Items | 24.8 | 56.14 | 26.92 | 63.06 | 15.06 | -66.63 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | -6.04 | Upgrade
|
| Gain (Loss) on Sale of Investments | -14.44 | -12.83 | -11.6 | -78.07 | -232 | 73.85 | Upgrade
|
| Gain (Loss) on Sale of Assets | 10.76 | 29.5 | -1.48 | 1.81 | -0.24 | 60.83 | Upgrade
|
| Asset Writedown | -23.22 | -86.48 | -20.13 | -80.62 | -56.95 | -181.67 | Upgrade
|
| Legal Settlements | - | - | - | 48.57 | - | - | Upgrade
|
| Other Unusual Items | 0.48 | 0.04 | 0.39 | -2.06 | -29.01 | 574.83 | Upgrade
|
| Pretax Income | -1.61 | -13.63 | -5.91 | -47.3 | -303.13 | 455.17 | Upgrade
|
| Income Tax Expense | -5.55 | -6.36 | -13.32 | 40.52 | 148.13 | 17.2 | Upgrade
|
| Earnings From Continuing Operations | 3.94 | -7.27 | 7.41 | -87.82 | -451.26 | 437.97 | Upgrade
|
| Earnings From Discontinued Operations | 2.72 | 11.32 | -4.07 | - | - | - | Upgrade
|
| Net Income to Company | 6.66 | 4.05 | 3.35 | -87.82 | -451.26 | 437.97 | Upgrade
|
| Minority Interest in Earnings | -1.87 | -19.4 | -23.86 | -21.09 | 75.27 | 0.58 | Upgrade
|
| Net Income | 4.8 | -15.36 | -20.52 | -108.91 | -376 | 438.55 | Upgrade
|
| Net Income to Common | 4.8 | -15.36 | -20.52 | -108.91 | -376 | 438.55 | Upgrade
|
| Net Income Growth | -39.69% | - | - | - | - | 487.65% | Upgrade
|
| Shares Outstanding (Basic) | 1,149 | 1,181 | 1,216 | 1,232 | 1,232 | 1,232 | Upgrade
|
| Shares Outstanding (Diluted) | 1,149 | 1,181 | 1,216 | 1,232 | 1,232 | 1,232 | Upgrade
|
| Shares Change (YoY) | -4.83% | -2.87% | -1.25% | - | - | -1.32% | Upgrade
|
| EPS (Basic) | 0.00 | -0.01 | -0.02 | -0.09 | -0.31 | 0.36 | Upgrade
|
| EPS (Diluted) | 0.00 | -0.01 | -0.02 | -0.09 | -0.31 | 0.36 | Upgrade
|
| EPS Growth | -36.63% | - | - | - | - | 495.53% | Upgrade
|
| Free Cash Flow | 153.37 | 157.04 | 134.89 | 143.07 | 353.05 | -39.33 | Upgrade
|
| Free Cash Flow Per Share | 0.13 | 0.13 | 0.11 | 0.12 | 0.29 | -0.03 | Upgrade
|
| Dividend Per Share | 0.030 | 0.030 | - | - | - | - | Upgrade
|
| Gross Margin | 51.08% | 50.37% | 47.31% | 41.26% | 39.87% | 45.47% | Upgrade
|
| Operating Margin | 0.82% | 5.21% | 0.69% | 5.00% | 1.25% | -21.32% | Upgrade
|
| Profit Margin | 0.63% | -1.96% | -2.83% | -7.83% | -33.92% | 70.65% | Upgrade
|
| Free Cash Flow Margin | 20.12% | 20.03% | 18.64% | 10.28% | 31.85% | -6.34% | Upgrade
|
| EBITDA | 56.09 | 92.58 | 59.6 | 130.58 | 72.83 | -81.59 | Upgrade
|
| EBITDA Margin | 7.36% | 11.81% | 8.24% | 9.38% | 6.57% | -13.14% | Upgrade
|
| D&A For EBITDA | 49.84 | 51.7 | 54.61 | 61 | 59 | 50.77 | Upgrade
|
| EBIT | 6.24 | 40.88 | 4.99 | 69.58 | 13.83 | -132.36 | Upgrade
|
| EBIT Margin | 0.82% | 5.21% | 0.69% | 5.00% | 1.25% | -21.32% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 3.78% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.